Tumor Volume Combined With Number of Positive Lymph Node Stations Is a More Important Prognostic Factor Than TNM Stage for Survival of Non–Small-Cell Lung Cancer Patients Treated With (Chemo)radiotherapy

2008 ◽  
Vol 70 (4) ◽  
pp. 1039-1044 ◽  
Author(s):  
Cary Dehing-Oberije ◽  
Dirk De Ruysscher ◽  
Hiska van der Weide ◽  
Monique Hochstenbag ◽  
Gerben Bootsma ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Lymph Node ◽  
Prognostic Factor ◽  
Small Cell Lung Cancer ◽  
Cancer Patients ◽  
Tumor Volume ◽  
Positive Lymph Node ◽  
Small Cell ◽  
Small Cell Lung ◽  
Lung Cancer Patients

scholarly journals Tumor Volume Decrease at 8 Weeks Is Associated with Longer Survival in EGFR-Mutant Advanced Non–Small-Cell Lung Cancer Patients Treated with EGFR TKI

2013 ◽  
Vol 8 (8) ◽  
pp. 1059-1068 ◽  
Author(s):  
Mizuki Nishino ◽  
Suzanne E. Dahlberg ◽  
Stephanie Cardarella ◽  
David M. Jackman ◽  
Michael S. Rabin ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cancer Patients ◽  
Tumor Volume ◽  
Small Cell ◽  
Small Cell Lung ◽  
Lung Cancer Patients ◽  
Egfr Mutant ◽  
Egfr Tki ◽  
Volume Decrease

Validity of using lobe-specific regional lymph node stations to assist navigation during lymph node dissection in early stage non-small cell lung cancer patients

Surgery Today ◽  
2013 ◽  
Vol 44 (11) ◽  
pp. 2028-2036 ◽  
Author(s):  
Shinichiro Miyoshi ◽  
Kazuhiko Shien ◽  
Shinichi Toyooka ◽  
Kentaroh Miyoshi ◽  
Hiromasa Yamamoto ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Lymph Node ◽  
Small Cell Lung Cancer ◽  
Cancer Patients ◽  
Early Stage ◽  
Regional Lymph Node ◽  
Small Cell ◽  
Node Dissection ◽  
Small Cell Lung ◽  
Lung Cancer Patients
Sign in / Sign up

Export Citation Format

Share Document